Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

European stocks gain; banks rise, chemicals fall

Published 08/27/2009, 09:49 AM
Updated 08/27/2009, 09:51 AM
UBSN
-
CAGR
-
NDASE
-

* FTSEurofirst 300 index up 0.1 percent

* Banks gain, Bayer down

* U.S. GDP unchanged, jobless claims fall

By Joanne Frearson LONDON, Aug 27 (Reuters) - European shares ticked higher in afternoon trade after briefly turning negative on Thursday, following weekly U.S. jobless claims data and confirmation that the U.S. economy shrank less than expected in the second quarter.

By 1326 GMT, the pan-European FTSEurofirst 300 index of top shares was up 0.1 percent at 974.64 points after falling to a low of 970.59 earlier in the session.

"The U.S. GDP figures were not as bad as expected," said Peter Dixon, an economist at Commerzbank. "Markets have demonstrated a lot of volatility in recent days and I think markets will see-saw on the back of good and bad news."

"U.S. jobless figures were a little bit worse than expected, but still were an improvement on the previous week. These numbers are volatile and I would not want to base any kind of assessment on these numbers," he said.

U.S. jobless claims fell last week to 570,000, slightly above the 565,000 predicted by analysts.

Data also showed the U.S. economy contracted at an annualised rate of 1.0 percent in the second-quarter, the same as its initial reading. Analysts had predicted a downwardly revised reading of minus 1.5 percent.

Banks were among the top movers on the European index. UBS, Barclays, Credit Agricole and Nordea Bank were 2.2 to 4.7 percent higher.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On the downside, the chemical sector was the worst performers. German drugmaker Bayer slipped 4.4 percent after traders pointed to concerns that peer Boehringer Ingelheim may report strong data about its rival drug to Bayer's anti-blood-clotting pill Xarelto.

A Reuters poll has shown leading investors have kept their portfolios steady in August, as the northern summer doldrums and caution about how far the global equity market rally can go led many to sit back and wait. (Editing by Jon Loades-Carter)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.